Company Profiles

driven by the PitchBook Platform

ACT Genomics

ACT Genomics
2014 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Series B LATEST DEAL TYPE
$12.5M LATEST DEAL AMOUNT
$20.5M TOTAL AMOUNT RAISED
Description

Provider of cancer molecular information services. The company's implements next generation sequencing and multiplex molecular testing platform, coupling with bioinformatics tool, curated proprietary databases and data visualization technologies to address the key challenges in cancer treatments.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Other Healthcare
Primary Office
1F., Number 280
Xinhu 2nd Road, Neihu District
Taipei City, 114
Taiwan

+886 (0)22 7953660
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ACT Genomics’s full profile, request a free trial.

ACT Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 01-May-2016 $12.5M $20.5M Completed Startup
1. Early Stage VC (Series A) 13-Feb-2015 000 000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

ACT Genomics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CDIB Capital International PE/Buyout Minority 000 0000 000000 0
Eminent Venture Capital Venture Capital Minority 000 0000 000000 0
Hotung Investment Holdings Venture Capital Minority 000 0000 000000 0
Hua Nan Venture Capital Venture Capital Minority 000 0000 000000 0
President International Development Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

ACT Genomics Executive Team (3)

Name Title Board
Seat
Contact
Info
PJ Hsueh Chief Operating Officer
Hua-Chien Chen Ph.D Co-Founder & Chief Executive Officer
Shu-Jen Chen Ph.D Co-Founder & Chief Scientific Officer